Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Axsome Therapeutics - AXSM - Stock Price & News | The ... Real time Axsome Therapeutics (AXSM) stock price quote, stock graph, news & analysis. AXAS: Message Board for Abraxas Petroleum Corporation ... Abraxas Petroleum Corporation Message board - Online Community of active, educated investors researching and discussing Abraxas Petroleum Corporation Stocks. Axsome Therapeutics: Buy at the High? | The Motley Fool
Axsome Therapeutics, Inc. (AXSM) Stock Analysis & News ...
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and others. Sage Therapeutics, Inc. (SAGE) Stock Forum & Discussion ... Find the latest Sage Therapeutics, Inc. (SAGE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 3Pea International Inc. PAYSIGN (PAYS) Stock Message Board ... Paysign Inc. (PAYS) is an experienced and trusted prepaid debit card payment solutions provider as well as an integrated payment processor that has over 2 million of prepaid debit cards in its portfolio.PaySign designs and develops payment solutions, prepaid card programs, and customized payment services. The Company manages programs for many of the world’s largest pharmaceutical TMF: AXSM / Saul’s Investing Discussions
Axsome Therapeutics, Inc. (AXSM) Stock Price, Quote ...
AXAS: Message Board for Abraxas Petroleum Corporation ... Abraxas Petroleum Corporation Message board - Online Community of active, educated investors researching and discussing Abraxas Petroleum Corporation Stocks. Axsome Therapeutics: Buy at the High? | The Motley Fool
The bulk of my portfolio at year end is in biotech, 84%. My portfolio was up 215% for the year, thanks mostly to AXSM, 77% of my portfolio. I have always appreciated people on these boards who give us their personal experience with tech, and for the first time in my life I felt that I had inside information on a stock.
Axsome Therapeutics (AXSM) | Stock Discussion Forums Undiscovered and massive undervalued Biotech Stock with many Big News on the way . Axsome has 5 Phase 3 in various indication targeting very large Markets including Alzheimer and Depression .This Stock is brutally undervalued with Market cap of $83 million and $50 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) over 50% of O/S is owned by Insider TMF: Re: AXSM / Where Angels Fear to Tread
Axsome Therapeutics Historical Data - AXSM | ADVFN
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. AXSM Stock Forecast - Buy or Sell? Axsome Therapeutics Axsome Therapeutics fell by -0.23% in the last day ( Thursday, 2nd Apr 2020 ) from $55.79 to $55.66 and has now fallen 3 days in a row. During the day the stock fluctuated 5.34% from a day low at $53.77 to a day high of $56.64.The price has been going up and down for this period, and there has been a 19.78% gain for the last 2 weeks. AXSM Stock News and Price / Axsome Therapeutics, Inc ... AXSM / Axsome Therapeutics, Inc. 10-K - Annual Report - 10-K. 03-12 sec.gov Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) …